Search results
- 1.0551303 - ÚI 2022 GB eng A - Abstract
Cibula, D. - Havel, L. - Zemanová, M. - Pešek, M. - Kolek, V. - Spíšek, R. - Bartůňková, J. - Pecen, Ladislav - Krasnopolskaya, I. - Černovská, M.
Dendritic-cell vaccine (DCVAC) with first line chemotherapy in patients with stage IV NSCLC primary analysis of phase 2, open-label, randomized, multicenter trial.
Journal of Clinical Oncology. Roč. 36, 15 S (2018), s. 9051. ISSN 0732-183X. E-ISSN 1527-7755
Permanent Link: http://hdl.handle.net/11104/0326730 - 2.0551302 - ÚI 2022 GB eng A - Abstract
Rob, L. - Mallmann, P. - Knapp, P. - Melichar, B. - Klat, J. - Minář, L. - Novotný, Z. - Bartůňková, J. - Spíšek, R. - Pecen, Ladislav - Bin Hassan, H. I. - Cibula, D.
Dendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with epithelial ovarian carcinoma (EOC) after primary debulking surgery (PDS): Interim analysis of a phase 2, open-label, randomized, multicenter trial.
Journal of Clinical Oncology. Roč. 36, 15 S (2018), s. 5509. ISSN 0732-183X. E-ISSN 1527-7755
Permanent Link: http://hdl.handle.net/11104/0326729 - 3.0506303 - ÚI 2020 US eng A - Abstract
Cibula, D. - Rob, L. - Mallmann, P. - Knapp, P. - Bartůňková, J. - Spíšek, R. - Hassan, H. I. - Pecen, Ladislav - Klat, J. - Chovanec, J.
Dendritic cell-based immunotherapy (DCVAC/OvCa) withchemotherapy in patients with platinum-sensitive, relapsed,epithelial ovarian carcinoma: Survival analysis of a phase II,open-label, randomized, multicenter trial (study SOV02).
Gynecologic Oncology. Elsevier. Roč. 154, suppl. 1 (2019), s. 18-18. ISSN 0090-8258. E-ISSN 1095-6859.
[Annual Meeting of the Society of Gynecologic Oncology /50./. 16.03.2019-19.03.2019, Honolulu]
Institutional support: RVO:67985807
Permanent Link: http://hdl.handle.net/11104/0297589 - 4.0506302 - ÚI 2020 eng A - Abstract
Havel, L. - Kolek, V. - Pešek, M. - Černovská, M. - Bartůňková, J. - Spíšek, R. - Pecen, Ladislav - Krasnopolskaya, I. - Zemanová, M.
Dendritic-cell vaccine (DCVAC) with first-line chemotherapy in patients with stage IV NSCLC: Final analysis of phase II, open label, randomized, multicenter trial.
Journal of Clinical Oncology. Roč. 37, suppl (2019), s. 9039-9039. ISSN 0732-183X. E-ISSN 1527-7755
https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.9039
Permanent Link: http://hdl.handle.net/11104/0297588 - 5.0506294 - ÚI 2020 eng A - Abstract
Havel, L. - Zemanová, M. - Pešek, M. - Kolek, V. - Spíšek, R. - Bartůňková, J. - Pecen, Ladislav - Krasnopolskaya, I. - Černovská, M.
Dendritic-cell vaccine (DCVAC) with first line chemotherapy in patients with stage IV NSCLC primary analysis of phase 2, open-label, randomized, multicenter trial.
Journal of Clinical Oncology. Roč. 36, 15 suppl (2018), s. 9051-9051. ISSN 0732-183X. E-ISSN 1527-7755
Permanent Link: http://hdl.handle.net/11104/0297583 - 6.0492757 - ÚI 2019 eng A - Abstract
Rob, L. - Mallmann, P. - Knapp, P. - Melichar, B. - Klat, J. - Minář, L. - Novotný, Z. - Bartůňková, J. - Spisek, R. - Pecen, Ladislav - Hassan, H. I. - Cibula, D.
Dendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with epithelial ovarian carcinoma (EOC) after primary debulking surgery (PDS): Interim analysis of a phase 2, open-label, randomized, multicenter trial.
Journal of Clinical Oncology. Roč. 36, 15 Suppl. (2018), s. 5509. ISSN 0732-183X. E-ISSN 1527-7755.
[ASCO 2018 Annual Meeting. 01.06.2018-05.06.2018, Chicago]
Keywords : Gynecologic Cancer * Ovarian Cancer
http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.5509
Permanent Link: http://hdl.handle.net/11104/0286134 - 7.0492756 - ÚI 2019 eng A - Abstract
Cibula, D. - Mallmann, P. - Knapp, P. - Melichar, B. - Klat, J. - Minář, L. - Novotný, Z. - Wimberger, P. - Hein, A. - Spisek, R. - Bartůňková, J. - Pecen, Ladislav - Hassan, H. I. - Rob, L.
Dendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with recurrent epithelial ovarian carcinoma (EOC) after complete response (CR) to 1st-line platinum (Pt)-based ct: Primary analysis of a phase 2, open-label, randomized, multicenter trial.
Journal of Clinical Oncology. Roč. 36, 15 Suppl. (2018), e17515. ISSN 0732-183X. E-ISSN 1527-7755.
[ASCO 2018 Annual Meeting. 01.06.2018-05.06.2018, Chicago]
http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e17515
Permanent Link: http://hdl.handle.net/11104/0286133 - 8.0190476 - UMG-J 980176 GB eng A - Abstract
Bartůňková, J. - Šedivá, A. - Malý, Petr - Smetana, K. - Klubal, R. - Hrušák, O. - Sedláček, A.
Fucosyltransferse VII-knock-out mouse - animal model for anew LAD syndrome.
1998. Molecular Immunology. Elsevier. s. S725. ISSN 0161-5890. E-ISSN 1872-9142.
[Meeting of the European Society for Immunodeficiency /8./. 08.10.1998-11.10.1998, Rhodos]
R&D Projects: GA ČR GA301/97/0234
Grant - others:GA UK ČR(CZ) 177/1998
Subject RIV: EB - Genetics ; Molecular Biology
Permanent Link: http://hdl.handle.net/11104/0086259 - 9.0187500 - UMCH-V 990013 CZ cze A - Abstract
Smetana ml., Karel - Vacík, Jiří - Bartůňková, J. - Lukáš, Jaromír - Michálek, Jiří - Dvořánková, B. - Palečková, Věra
Molekulární mechanismy biokompatibility.
[Molecular mechanisms of biocompatibility.]
Skelet 99. Praha: Centrum BioMedicínského Inženýrství ČVUT, 1999. s. 56-57.
[Skelet 99. 24.02.1999-25.02.1999, Praha]
R&D Projects: GA ČR GA304/98/0267
Subject RIV: FE - Other Internal Medicine Disciplines
Permanent Link: http://hdl.handle.net/11104/0083578